Bedside Glucose Monitoring Designed for the ICU/CCU
  • The OptiScanner is an automated, plasma-based bedside glucose monitoring system intended to assist healthcare providers manage the glucose level of critically ill patients within an optimum target range.

  • The system draws a small amount of patient blood (only consuming
    0.12 mL per draw) every 15 minutes, converts the blood to plasma in
    a micro-centrifuge and then transports the plasma to be read by
    mid-range infrared spectrometer

  • A proprietary algorithm automatically adjusts for interferences and within a few minutes of the blood draw, a glucose reading is displayed on the front of the OptiScanner.

  • Because the OptiScanner provides a glucose reading every 15 minutes, glycemic trends can be displayed prominently, indicating whether patient’s glucose is stable (euglycemia), rising too high (hyperglycemia)
    or falling too low (hypoglycemia).

  • Healthcare providers can use the OptiScanner to track a patient’s glucose and use trending data to aid in decision making and potentially help patients stay in a healthy glycemic range.

  • Certified by .
Demonstration Video

Learn how the OptiScanner will work in a hospital setting.
Click here for more information >>
Latest Updates

Read the latest updates about the OptiScanner.
Click here for more information >>
Optiscan 5000
Home | More Information | Site Map

© OptiScan Biomedical Corporation. All rights reserved.